Borate-Based Drug And Use Thereof
AssigneeChengdu Origin Biotechnology Limited Company
InventorsPeng He, Haiyan Li, Hai Zhao, Pei Huang, Xuechao Wang
Life of this patent
Estimating the term…
Loading patent…
AssigneeChengdu Origin Biotechnology Limited Company
InventorsPeng He, Haiyan Li, Hai Zhao, Pei Huang, Xuechao Wang
Estimating the term…
The present application provides a borate ester compound suitable for being used as a proteasome inhibitor, a preparation method and use thereof, and the compound has the following structure wherein, R1, R2 is asymmetric substituent in para-position, and R1 and R2 are both selected from the group consisting of halogen; and when R1 is F, R2 is not Cl; when R1 is Cl, R2 is not Br or F; and when R1 is Br, R2 is not Cl; X1, X2 is selected from the group consisting of hydroxyl, or X1 and X2 together form a substituted or unsubstituted 4 to 10 membered ring containing 1 to 4 heteroatoms being selected from the group consisting of O, N and S.
1-6. (canceled)
A compound of formula (I′) or stereoisomers, enantiomers, tautomers or mixture thereof, or pharmaceutically acceptable salts, solvates, prodrugs or boric anhydride thereof
(canceled)
Dependencies are inferred from the claim text.